Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INSMED Inc Director's Dealing 2020

Dec 9, 2020

30150_dirs_2020-12-09_a2bfb3d7-a39d-4c37-9ffa-2a4389d08433.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2020-12-07

Reporting Person: ALTOMARI ALFRED (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-12-07 Common Stock S 20000 $39.57 Disposed 20938 Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2: This is the weighted average sales price representing 20,000 shares sold at prices ranging from $39.01 to $40.14 per share. The number sold at each price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.